Alexis Knutson United States

• INTRODUCTION TO ONCOPLASTIC BREAST SURGERY: INDICATIONS AND PATIENT SELECTION
  951-1
  LilianaCastrezana Lopez Speaker Switzerland
• PRINCIPLES OF ONCOPLASTIC SURGERY (VOLUME DISPLACEMENT vs. VOLUME REPLACEMENT)
  951-2
  KaryneMartel Speaker Canada
• BASIC TECHNIQUES: DE-EPITHELIALIZATION, DUAL PLANE MOBILISATION, AND SCAR PLACEMENT
  951-3
  Pooja Ramakant Speaker India
• BREAST CONSERVING Vs. MASTECTOMY: WHAT WOULD AN ONCOPLASTIC BREAST SURGEON DO?
  951-4
  SandraKrishnan Speaker Australia
• DISCUSSION
  951-5
• ROUND BLOCK (BENELLI) and VERTICAL MAMMOPLASTY
  951-6
  LilianaCastrezana Lopez Speaker Switzerland
• WISE PATTERN REDUCTION MAMMOPLASTY
  951-7
  IsabellaKarat Speaker United Kingdom
• THE OTHER THERAPEUTIC MAMMOPLASTY TECHQNIUES (BATWING, GRISOTTI, B-PLASTY)
  951-8
  Christoph Johannes Tausch Speaker Switzerland
• WHICH TECHNIQUE SHOULD I USE? PATIENT SELECTION AND QUADRANT BY QUADRANT APPROACH.
  951-9
  Christoph Johannes Tausch Speaker Switzerland
• CHEST WALL PERFORATOR FLAP ANATOMY, TYPES (LICAP, MICAP AND LTAP) AND MARKING
  951-10
  Farid Meybodi Speaker Australia
• MODIFICATION OF THE CHEST WALL FLAPS, PRACTICAL TIPS AND TRICKS
  951-11
  Farid Meybodi Speaker Australia
• FAT GRAFTING AND NIPPLE RECONSTRUCTION
  951-12
  Susanna Minna CeciliaKauhanen Speaker Finland
• DISCUSSION
  951-13
• INTERACTIVE SESSIONS
  951-14
• HOW TO DO A GOOD SIMPLE MASTECTOMY?
  951-16
  IsabellaKarat Speaker United Kingdom
• SKIN AND NIPPLE SPARING MASTECTOMY: PITFALLS TO AVOID
  951-17
  JiongWu Speaker China
• IMPLANT AND TISSUE EXPANDER RECONSTRUCTION
  951-18
  Ashutosh Kothari Speaker United Kingdom
• MESH AND ADM SELECTION
  951-19
  Ashutosh Kothari Speaker United Kingdom
• MANAGEMENT OF COMPLICATIONS OF ONCOPLASTIC SURGERY
  951-20
  Susanna Minna CeciliaKauhanen Speaker Finland
• TRAINING PATHWAY FOR ONCOPLASTIC SURGERY
  951-21
  KavithaDaester Speaker Switzerland
• DISCUSSION
  951-22

• BREAST CANCER IN PREGNANCY
  125-1
  Jacqueline Sara Jeruss Speaker United States
• GENETIC MUTATIONS: HOW MUCH RISK IN EACH?
  125-2
  Sergio IsraelAguilar Villanueva Speaker Mexico
• RISK-REDUCING SURGERY: WHEN AND WHAT
  125-3
  Elisa R.Port Speaker United States
• HORMONAL THERAPIES: BIRTH CONTROL; HRT
  125-4
  Versha Pleasant Speaker United States

• ONCOFERTILITY
  126-1
  Jacqueline Sara Jeruss Speaker United States
• MANAGING SIDE-EFFECTS OF ADJUVANT ENDOCRINE THERAPY
  126-2
  RobinShaw Dulin Speaker Mexico
• SEXUAL HEALTH AFTER BREAST CANCER THERAPY
  126-3
  Cintia MaríaSepúlveda Rivera Speaker Mexico
• PSYCHO-SOCIAL SUPPORT AND SURVIVAL ISSUES
  126-4
  MonicaRamirez Speaker Mexico

• COMPARISON OF MAMMAPRINT VERSUS ONCOTYPE DX IN PREDICTING RISK OF BREAST CANCER RECURRENCE
  PW04-01
  Alexis Knutson Speaker United States
• THE IMPACT OF EUSOMA ACCREDITATION ON BREAT CACER PATIENTS MANAGEMENT IN A SINGLE ITALIAN CENTER
  PW04-02
  Ambrogio P Londero Speaker Italy
• FEASIBILITY OF BREAST CARE NURSE MULTI-STEP EVALUATION IN IMPROVING QUALITY OF CARE FOR BREAST CANCER PATIENTS
  PW04-03
  Ambrogio P Londero Speaker Italy
• REINFORCED AND NON-REINFORCED BIOLOGIC MESH VERSUS NO MESH FOR DIEP FLAP DONOR SITE REINFORCEMENT: COMPARATIVE OUTCOMES IN ABDOMINAL MORBIDITY
  PW04-04
  ArnavMahajan Speaker United States
• OCCULT BREAST CANCER – WHERE DOES THE FUTURE TAKE US?
  PW04-05
  BeatrizCordeiro Speaker Portugal
• CURRENT PRACTICES AND TRENDS OF BREAST-CONSERVING SURGERY IN CHINA: A NATIONWIDE CROSS-SECTIONAL SURVEY
  PW04-07
  HanZhu Speaker China
• IMPACT OF BREAST RECONSTRUCTION ON QOL (QUALITY OF LIFE) IN BREAST CANCER PATIENTS FOLLOWING NIPPLE-SPARING MASTECTOMY (NSM)
  PW04-08
  HidetakaWatanabe Speaker Japan
• OUR SUCCESSFUL METHOD OF REPEATED AIR APPLICATION WITH BETADINE WITH REMAINING SLIGHT OVERPRESSURE IN THE BREAST CAVITY IN PERI- AND POSTOPERATIVE CARE IN PATIENTS AFTER EXTENSIVE BREAST CONSERVING SURGERY FOR CANCER.GOOD RESULTS IN A FIVE-YEAR FOLLOW UP.
  PW04-09
  JindřichŠuk Speaker Czech Republic
• CLINICOPATHOLOGIC PROFILE OF BREAST CANCER IN THE YOUNG MANAGED IN COTABATO REGIONAL MEDICAL CENTER: A 5 YEARS RETROSPECTIVE STUDY
  PW04-10
  Mohammad BakryAbdulcader Speaker Philippines
• RE-SENTINEL NODE BIOPSY IN PATIENTS WITH IPSILATERAL BREAST CANCER RECURRENCE AFTER BREAST CONSERVING SURGERY
  PW04-11
  RieSugihara Speaker Japan
• DOES AGE IMPACT BREAST CANCER OUTCOMES IN INDIAN WOMEN? RESULTS FROM A 5-YEAR COHORT STUDY FROM NORTH INDIA
  PW04-12
  RinelleMascarenhas Speaker India
• A RANDOMIZED CONTROL CLINICAL TRIAL TO STUDY INSTILLATION OF LOCAL ANTIBIOTIC THERAPY WITH SUCTION DRAINAGE SYSTEM FOR MANAGEMENT OF BREAST ABSCESSES
  PW04-13
  SejalGrover Speaker India
• OST- DIAGNOSIS WEIGHT TRAJECTORIES IN CASE OF BREAST CARCINOMA AND FACTORS ASSOCIATED WITH IT
  PW04-14
  SejalGrover Speaker India
• THE SHADOW OF CURE: IMPACT OF AXILLARY LYMPH NODE DISSECTION AND ADJUVANT RADIOTHERAPY ON DEVELOPMENT OF LYMPHOEDEMA AMONG BREAST CANCER PATIENTS IN NORTHERN SRI LANKA
  PW04-15
  SittampalamRajendra Speaker Sri Lanka
• RISK OF AXILLARY NODAL METASTASIS IN HER2-POSITIVE AND TRIPLE-NEGATIVE BREAST CANCER: EXPLORATION FOR OMISSION OF SENTINEL LYMPH NODE BIOPSY
  PW04-17
  Ki-TaeHwang Speaker South Korea
• TWO BREASTS, TWO ENTITIES: SYNCHRONOUS CARCINOMA AND MALT LYMPHOMA
  PW04-18
  Maria Gualter Baptista Speaker Portugal
• ANTITUMOR EFFECTS OF EVAPORATED COMPONENTS OF MAGNOLIA SALICIFOLIA ESSENTIAL OIL FOR BREAST CANCER
  PW04-19
  TakuyaNagata Speaker Japan
• CURRENT PRACTICES AND CHALLENGES OF AUTOLOGOUS BREAST RECONSTRUCTION IN CHINA: A QUESTIONNAIRE-BASED AND NATIONWIDE CROSS-SECTIONAL SURVEY OF 198 HOSPITALS
  PW04-20

• INFLAMMATORY BREAST CANCER: DO’S AND DON’T’S
  222-1
  Pooja Ramakant Speaker India
• RECONSTRUCTIVE OPTIONS IN LABC: WHEN AND HOW?
  222-2
  Adeyiza Momoh Speaker United States
• MANAGING RECURRENCES: BREAST/ CHESTWALL AND AXILLA
  222-3
  EsmeraldaRomero Bañuelos Speaker Mexico
• MDT CASE DISCUSSION: INTEGRATING THERAPY
  222-4
  Christoph Johannes Tausch Panelist Switzerland

  Tadahiko Shien Panelist Japan

• TARGETED AXILLARY DISSECTION (FOLLOWING NEOADJUVANT SYSTEMIC THERAPY FOR (HER2+ OR TNBC) OR UPFRONT SURGERY IN HORMONE RECEPTOR POSITIVE) FOR CN1 DISEASE
  223-1
  KandaceMcGuire Speaker United States
• OMISSION OF RADIATION POST BREAST CONSERVING SURGERY
  223-2
  NereidaEsparza Arias Speaker Mexico
• OMISSION OF SENTINEL LYMPH NODE BIOPSY FOR INVASIVE BREAST CANCER (SOUND, NAUTILUS, SOAPET, BOOG 2013-08, INSEMA)
  223-3
  HelenJohnson Speaker United States
• ACTIVE SURVEILLANCE FOR DCIS (COMET TRIAL, LORD, LORIS)
  223-4
  E. ShelleyHwang Speaker United States
• OMISSION OF BREAST SURGERY IN EARLY BREAST CANCER
  223-5
  MarkBasik Speaker Canada

• INTEGRATING PERSONAL, HEREDITARY, AND POLYGENIC PROFILES VIA DEEP LEARNING-BASED RISK ESTIMATION FOR PRECLINICAL BREAST CANCER DIAGNOSIS
  3103-01
  SaturninoDomínguez Speaker Panama
• “THE TRIPLE TROUBLE” -VIRAL MARKER POSITIVITY, TUMOR AGGRESSIVENESS, AND OPPORTUNISTIC INFECTIONS IN BREAST CANCER
  3103-02
  BharathShivalingaiah Speaker India
• THE ASSOCIATION OF BODY MASS INDEX (BMI) AND HEIGHT WITH ONCOTYPE DX SCORES IN WOMEN WITH HORMONE RECEPTOR POSITIVE HER 2 NEGATIVE BREAST CANCER IN THE NYC METROPOLITAN AREA
  3103-03
  GeorgiaSyrnioti Speaker United States
• THE IMPACT OF METABOLIC SYNDROME ON THE DIAGNOSIS OF SECOND PRIMARY TUMORS IN WOMEN TREATED FOR BREAST CANCER: A RETROSPECTIVE COHORT ANALYSIS
  3103-04
  Ambrogio P Londero Speaker Italy
• INFLUENCE OF GERIATRIC ASSESSMENT ON TREATMENT DECISIONS IN ELDERLY BREAST CANCER PATIENTS
  3103-05
  Ambrogio P Londero Speaker Italy
• THE DIAGNOSTIC ACCURACY OF TUMOR BED BIOPSY IN PREDICTING PATHOLOGICAL COMPLETE RESPONSE IN BREAST CANCER AFTER NEO ADJUVANT CHEMOTHERAPY: A META-ANALYSIS RUNNING TITLE: TUMOR BED BIOPSY FOR PCR ASSESSMENT
  3103-06
  Garvit Garg Speaker India
• EXTERNAL VALIDATION OF THE MSKCC NOMOGRAM FOR PREDICTING SENTINEL NODE STATUS IN EARLY BREAST CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS
  3103-07
  JustinJames Speaker Australia
• MINIMALLY INVASIVE RADIOFREQUENCY ABLATION (RFA) THERAPY IN PATIENTS WITH EARLY-STAGE BREAST CANCER
  3103-08
  UhiToh Speaker Japan
• CLINICAL CHARACTERISTICS OF HER2-LOW BREAST CANCER COMPARED TO HER2-NEGATIVE BREAST CANCER
  3103-09
  Cheng-Har Yip Speaker Malaysia
• MICROWAVE ABLATION FOR INOPERABLE EARLY BREAST CANCER: A MINIMALLY INVASIVE OPTION FOR HIGH-RISK PATIENTS
  3103-10
  Garvit Garg Speaker India
• ENDOSCOPIC BREAST SURGERY FOR PERSONALIZATION OF BREAST CANCER TREATMENT
  3103-11
  KojiYamashita Speaker Japan
• SHIFTING PRACTICE PATTERNS IN IMPLANT-BASED BREAST RECONSTRUCTION IN CHINA: INSIGHTS FROM A 13-YEAR LARGE-SCALE RETROSPECTIVE COHORT
  3103-12
  ZhiboShao Speaker China